Je veux savoir à propos de…

Federal Register / Vol. 86, No. 36 / Thursday, February 25, 2021 / Notices B. Federal Reserve Bank of Kansas City Dennis Denney, Assistant Vice President 1 Memorial Drive, Kansas City, Missouri 641980001:
1. Lance L. White, as co-trustee of the Lance L. White Revocable Trust and as trustee of the Lance L. White Irrevocable Trust, and Cherlyn D. White, as trustee of the Cherlyn D. White-Conklin Irrevocable Trust and as co-trustee of the Cherlyn White-Conklin Trust, all of Wamego, Kansas; and Monte W. White, individually, and as trustee of the MWW
Irrevocable Trust 1, both of Salina, Kansas; as members of the White Family Group, a group acting in concert, to retain voting shares of Wamego Bancshares, Inc., and thereby indirectly retain voting shares of Bank of the Flint Hills, both of Wamego, Kansas.
Additionally, Kara L. White, as cotrustee of the Lance L. White Revocable Trust, Cherlyn White-Conklin Trust, Erich Conklin, as co-trustee, and certain minor children, all of Salina and Wamego, Kansas; to join the White Family Group, and retain voting shares of Wamego Bancshares, Inc., and thereby indirectly retain voting shares of Bank of the Flint Hills.
Board of Governors of the Federal Reserve System, February 19, 2021.
Michele Taylor Fennell, Deputy Associate Secretary of the Board.
FR Doc. 202103841 Filed 22421; 8:45 am BILLING CODE P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and Prevention Docket No. CDC20210021

Advisory Committee on Immunization Practices ACIP
Centers for Disease Control and Prevention CDC, Department of Health and Human Services HHS.
ACTION: Notice of meeting and request for comment.
AGENCY:

In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention CDC, announces the following meeting of the Advisory Committee on Immunization Practices ACIP. This meeting is open to the public. Time will be available for public comment. The meeting will be webcast live via the World Wide Web.
DATES: The meeting will be held on February 28, 2021March 1, 2021, from 10:00 a.m. to 5:00 p.m. EDT times subject to change. Written comments SUMMARY:

VerDate Sep<11>2014

17:04 Feb 24, 2021

Jkt 253001

must be received on or before March 1, 2021.
ADDRESSES: For more information on ACIP please visit the ACIP website:
http www.cdc.gov/vaccines/acip/
index.html.
You may submit comments, identified by Docket No. CDC20210021 by any of the following methods:
Federal eRulemaking Portal:
https www.regulations.gov. Follow the instructions for submitting comments.
Mail: Docket No. CDC20210021, c/o Attn: ACIP Meeting, Centers for Disease Control and Prevention, 1600
Clifton Road NE, MS H248, Atlanta, GA 303294027.
Instructions: All submissions received must include the Agency name and Docket Number. All relevant comments received in conformance with the https www.regulations.gov suitability policy will be posted without change to https www.regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to https www.regulations.gov.
Written public comments submitted 24 hours prior to the ACIP meeting will be provided to ACIP members before the meeting.
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, ACIP Committee Management Specialist, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, 1600 Clifton Road NE, MSH248, Atlanta, GA 30329
4027; Telephone: 4046398367; Email:
ACIP@cdc.gov.
SUPPLEMENTARY INFORMATION: In accordance with 41 CFR 1023.150b, less than 15 calendar days notice is being given for this meeting due to the exceptional circumstances of the COVID19 pandemic and rapidly evolving COVID19 vaccine development and regulatory processes.
The Secretary of Health and Human Services has determined that COVID19
is a Public Health Emergency.
Purpose: The committee is charged with advising the Director, CDC, on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children VFC program, along with schedules regarding dosing interval, dosage, and contraindications to administration of vaccines. Further, under provisions of the Affordable Care Act, section 2713 of the Public Health Service Act, immunization recommendations of the ACIP that have
PO 00000

Frm 00037

Fmt 4703

Sfmt 4703

11531

been approved by the Director of the Centers for Disease Control and Prevention and appear on CDC
immunization schedules must be covered by applicable health plans.
Matters To Be Considered: The agenda will include discussions on COVID19
vaccines. A recommendation vote is scheduled. Agenda items are subject to change as priorities dictate. For more information on the meeting agenda visit https www.cdc.gov/vaccines/acip/
meetings/meetings-info.html.
Meeting Information: The meeting will be webcast live via the World Wide Web; for more information on ACIP
please visit the ACIP website: http
www.cdc.gov/vaccines/acip/index.html.
Public Participation Interested persons or organizations are invited to participate by submitting written views, recommendations, and data. Please note that comments received, including attachments and other supporting materials are part of the public record and are subject to public disclosure. Do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name, contact information, or other information that identifies you in the body of your comments, that information will be on public display.
CDC will review all submissions and may choose to redact, or withhold, submissions containing private or proprietary information such as Social Security numbers, medical information, inappropriate language, or duplicate/
near duplicate examples of a mass-mail campaign. CDC will carefully consider all comments submitted into the docket.
CDC does not accept comment by email.
Written Public Comment: Written comments must be received on or before March 1, 2021. Oral Public Comment:
This meeting will include time for members of the public to make an oral comment. Oral public comment will occur before any scheduled votes including all votes relevant to the ACIPs Affordable Care Act and Vaccines for Children Program roles.
Priority will be given to individuals who submit a request to make an oral public comment before the meeting according to the procedures below.
Procedure for Oral Public Comment:
All persons interested in making an oral public comment at the February 28, 2021March 1, 2021 ACIP meeting must submit a request at http www.cdc.gov/
vaccines/acip/meetings/ no later than 11:59 p.m., EDT, February 25, 2021
according to the instructions provided.

E:FRFM25FEN1.SGM

25FEN1